张玉五,薛颖,张秉乾.丹参对恶性淋巴瘤患者高血浆纤维蛋白原的影响[J].中国中西医结合杂志,1988,(10):607-608,582 |
丹参对恶性淋巴瘤患者高血浆纤维蛋白原的影响 |
Effect of Salvia miltiorrhiza on Hyperfibrinogen in Patients with Malignant Lymphoma |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 血浆纤维蛋白原 恶性淋巴瘤 丹参 增效作用 恶性肿瘤患者 治疗方案 纤溶作用 统计学处理 负相关 肿瘤细胞 |
英文关键词: |
基金项目: |
|
摘要点击次数: 1093 |
全文下载次数: 892 |
中文摘要: |
对35例恶性淋巴瘤患者分组治疗,结果表明丹参对 COP 治疗方案有增效作用。血浆纤维蛋白原(Fg)测定显示恶性淋巴瘤患者组较正常对照组高(P<0.01)。COP方案治疗组疗后血浆 Fg 较疗前有所降低(P>0.5);丹参—COP 方案治疗组血浆 Fg 疗后较疗前明显降低(P<0.01)。血浆 Fg 含量与疗效呈负相关。提示丹参的促纤溶作用是其抗肿瘤作用的重要机制之一。 |
英文摘要: |
35 cases of malignant lymphoma were divided into two groups randomly,22 cases of which were treated with Salvia miltiorrhiza(SM)-COP therapy,and only 13 cases by COP therapy.In terms o’f short-term effect,it has been found that SM-COP therapy was more effective than COP therapy,P< 0.01.The experimental study showed that one of the mechanisms of SM against tumor is improving the hypercoagulation state through lowering the serum hyperfibrinogen,from 3.626±1.638 to 2.343± 0.576 mg/dl,P<0.01,which is significant in showing that promoting the fibrinolytic activity was closely related with the therapeutic effect,and was one of the antitumor mechanisms. |
关闭 |
|
|
|